Risk factors for emergence ofStenotrophomonas maltophilia in cystic fibrosis
- 14 June 2000
- journal article
- research article
- Published by Wiley in Pediatric Pulmonology
- Vol. 30 (1) , 10-15
- https://doi.org/10.1002/1099-0496(200007)30:1<10::aid-ppul3>3.0.co;2-q
Abstract
The number of patients with cystic fibrosis (CF) whose sputum culture has yielded Stenotrophomonas maltophilia has increased in the last 5 years at St. Christopher's Hospital for Children. We conducted a case‐control study to determine risk factors for recovery of S. maltophilia in respiratory secretions from patients with CF. We reviewed the outpatient and inpatient records of patients colonized with S. maltophilia between 1993 and 1997, and of age‐matched (at time of initial recovery of S. maltophilia) control patients with CF who had never had a positive sputum culture for S. maltophilia. Variables included age at time of CF diagnosis, gender, severity of CF (based on Shwachman‐Kulczycki (S‐K) scores and spirometry), frequency of hospitalizations, use of oral, intravenous, or inhaled antibiotics, and use of oral or inhaled corticosteroids in the 2 years prior to the first isolation of S. maltophilia from respiratory secretions. Statistical methods included stepwise logistic regression to determine risk factors for acquisition of S. maltophilia. During the study period, 58 patients with CF had a positive sputum or deep throat culture for S. maltophilia. The distribution of S. maltophilia acquisition by year increased from 7 patients in 1993 (incidence, 2.8%) to 16 in 1997 (incidence, 6.2%). Patients positive for S. maltophilia were found to have significantly worse growth parameters, S‐K score, and spirometric values than S. maltophilia‐negative CF controls (P < 0.05). Stepwise logistic regression demonstrated that treatment with long‐term antibiotics (P = 0.0016) and number of days of intravenous antibiotic therapy (P = 0.035) were significant risk factors for S. maltophilia colonization in our group of CF patients. We conclude that patients with CF whose respiratory secretions yield S. maltophilia have an overall worse clinical status at the time of initial S. maltophilia isolation than noncolonized patients, and that preceding treatment with antibiotics may have predisposed them to the acquisition of this bacterium in their respiratory secretions. Pediatr Pulmonol. 2000; 30:10–15.Keywords
This publication has 20 references indexed in Scilit:
- Role of anti-pseudomonal antibiotics in the emergence ofStenotrophomonas maltophilia in cystic fibrosis patientsEuropean Journal of Clinical Microbiology & Infectious Diseases, 1996
- Stenotrophomonas maltophilia in cystic fibrosis patientsEuropean Journal of Clinical Microbiology & Infectious Diseases, 1995
- Bacterial colonisation withXanthomonas maltophilia — A retrospective study in a cystic fibrosis patient populationInfection, 1994
- Controlled study of Pseudomonas cepacia and Pseudomonas maltophilia in cystic fibrosis.Archives of Disease in Childhood, 1992
- Xanthomonas maltophilia: An Emerging Nosocomial PathogenMayo Clinic Proceedings, 1989
- Pseudomonas cepacia colonization in patients with cystic fibrosis: Risk factors and clinical outcomeThe Journal of Pediatrics, 1985
- Occurrence and antimicrobial susceptibility of gram-negative nonfermentative bacilli in cystic fibrosis patientsDiagnostic Microbiology and Infectious Disease, 1985
- Pseudomonas cepacia infection in cystic fibrosis: An emerging problemThe Journal of Pediatrics, 1984
- Moxalactam-tobramycin-resistant Pseudomonas aeruginosa Isolates in Patients with Cystic FibrosisClinical Pediatrics, 1983
- Treatment of pulmonary infections in patients with cystic fibrosis: A comparative study of ticarcillin and gentamicinThe Journal of Pediatrics, 1977